Form 8-K - Current report:
SEC Accession No. 0001628280-24-035247
Filing Date
2024-08-06
Accepted
2024-08-06 16:53:39
Documents
13
Period of Report
2024-08-06
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K gral-20240806.htm   iXBRL 8-K 25375
  Complete submission text file 0001628280-24-035247.txt   152423

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gral-20240806.xsd EX-101.SCH 1904
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gral-20240806_lab.xml EX-101.LAB 22530
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gral-20240806_pre.xml EX-101.PRE 13045
16 EXTRACTED XBRL INSTANCE DOCUMENT gral-20240806_htm.xml XML 3386
Mailing Address 1525 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1525 O'BRIEN DRIVE MENLO PARK CA 94025 650-771-9796
GRAIL, Inc. (Filer) CIK: 0001699031 (see all company filings)

EIN.: 863673636 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42045 | Film No.: 241180199
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)